Century Therapeutics CEO Osvaldo Flores steps down; Gregory Russotti named interim CEO, Michael Diem appointed CFO

Century Therapeutics, Inc.

Osvaldo Flores stepped down as President, CEO, and Board member effective April 11, 2023; no disagreement with the company.
Board appointed Gregory Russotti (previously CTO) as Interim President and CEO; salary raised to $614,092.50.
Russotti received a one-time option grant of 318,750 shares at $3.16/share, vesting over 4 years.
Michael Diem, previously Chief Business Officer, promoted to CFO; compensation for new role TBD.
Board reduced from 8 to 7 members following Flores' departure.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Gregory Russotti

Interim President and Chief Executive Officer

IPSC · Century Therapeutics, Inc.

Effective: 2023-04-11
Filed: April 17, 2023, 7:59 PM ET

On April 11, 2023, the Board appointed Gregory Russotti as Interim President and Chief Executive Officer.

Role change

Michael Diem

Chief Financial Officer

IPSC · Century Therapeutics, Inc.

Effective: 2023-04-11
Filed: April 17, 2023, 7:59 PM ET

On April 11, 2023, the Board promoted Michael Diem to Chief Financial Officer.

Departed

Osvaldo Flores

President and Chief Executive Officer

IPSC · Century Therapeutics, Inc.

Effective: 2023-04-11
Successor: Gregory Russotti
Filed: April 17, 2023, 7:59 PM ET

Osvaldo Flores, Ph.D. stepped down as the President and Chief Executive Officer of Century Therapeutics, Inc. (the “Company”) and as a member of the Board of Directors of the Company (the “Board”) effective April 11, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Gregory Russotti was appointed as Interim President and Chief Executive Officer at Century Therapeutics, Inc..

Action: appointed
Role: Interim President and Chief Executive Officer

Exact text from the filing

On April 11, 2023, the Board appointed Gregory Russotti as Interim President and Chief Executive Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Diem changed role as Chief Financial Officer at Century Therapeutics, Inc..

Action: promoted
Role: Chief Financial Officer

Exact text from the filing

On April 11, 2023, the Board promoted Michael Diem to Chief Financial Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Osvaldo Flores departed as President and Chief Executive Officer at Century Therapeutics, Inc..

Action: stepped down
Role: President and Chief Executive Officer

Exact text from the filing

Osvaldo Flores, Ph.D. stepped down as the President and Chief Executive Officer of Century Therapeutics, Inc. (the “Company”) and as a member of the Board of Directors of the Company (the “Board”) effective April 11, 2023.

View on SEC.gov

Century Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-046197

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.